medigraphic.com
Colegio de Medicina Interna de México.

2011, Number 5

<< Back Next >>

Med Int Mex 2011; 27 (5)

Prognostic predictors of pneumonia mortality, due to influenza A H1N1 infection

Neri SJC, Barranco GLM, León MH, Tovar SA, Rendón MME, Flores MFJ

Language: Spanish
References: 28
Page: 421-428
PDF size: 491.24 Kb.


ABSTRACT

Background: Influenza is usually a self-limiting disease. In April 2009, a new type of influenza A H1N1 virus was discovered. There were a lot of cases with severe pneumonia associated to this virus, although the lethal cases were less than expected. However, we must be still alert for future severe cases of influenza AH1N1 pneumonia.
Objective: to determine prognostic predictors of pneumonia mortality, due to influenza A H1N1 infection.
Patients and methods: Adults treated at the National Institute of Respiratory Diseases (INER) during the period of April to June 2009. We included all those who required hospitalization for pneumonia. We analyzed the survival associated with the need of mechanical ventilation in intensive care and clinical conditions at admission (age, weight, history of chronic diseases, oxygen saturation, temperature, CPK level, LDH level and lymphocytopenia).
Results: 38 patients met the inclusion criteria, 26 male (68.4%) and 12 women (31.6%). The mean age was 37 years old (1 to 85). 23 (60.5%) needed mechanical ventilation, of which 17 patients (44.7%) died. The most important mortality risk factors were: lymphocytopenia at admission ≤ 1,000 mm3 (OR: 3.2 95% CI 1.1 to 27.5) and LDH › 1.000 U / L (OR: 7.6 95% CI 1.2 to 47). This marker had a sensitivity and specificity predictor for death of 70.6% and 67% respectively.
Conclusion: The mortality in this group was high, especially in those patients with lymphcytoopenia and elevated DHL.


REFERENCES

  1. Harper S, Klimov A, Uyeki T, Fukuda K. Influenza. Clin Lab Med 2002;22:863-882.

  2. Kumlin U, Olofsson S, Dimock K, Arnberga N. Sialic acid tissue distribution and influenza virus tropism. Influenza Other Respi Viruses 2008;2:147-154.

  3. Johansson BE, Bucher DE, Kilbourne ED. Purified Influenza Virus hemaglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J Virol 1989;63(3):1239-1246.

  4. McGeoch D, Fellner P, Newton C. Biochemistry Influenza virus genome consists of eight distinct RNA species. Proc Natl Acad Sci 1976;73(9):3045-3049.

  5. Salomon R, Webster RG. The Influenza Virus Enigma. Cell 2009;136(3):402-410.

  6. Carrat F, Flahault A. Influenza vaccine: The challenge of antigenic drift. Vaccine 2007; 25:6852-6862.

  7. Beigel JH. Influenza. Crit Care Med 2008;36(9):2260-2266.

  8. Mandell, Bennett and Dolin. Principles and Practice of Infectious Diseases. 6th ed. New York: Churchill Livingstone, 2005.

  9. Laidlaw PP. Epidemic influenza: a virus disease. Lancet 1935;1:1118-1124.

  10. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus. Update on Avian Influenza A (H5N1) Virus Infection in Humans. N Engl J Med 2008;358:261-263.

  11. Zimmer SM, Burke DS. Historical Perspective - Emergence of Influenza A (H1N1) viruses. N Engl J Med 2009;361:279-285.

  12. Brockwell-Staats C, Webster RG, Webby RJ. Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1). Influenza Other Respi Viruses 2009; 3(5):207-213.

  13. Parrish CR, Holmes EC, Morens DM, et al. Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol Mol Biol Rev 2008;72:457-470.

  14. www.who.int/en/index.html

  15. Pourbohloul B, Ahued A, Davoudi B, et al. Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America. Influenza Other Respi Viruses 2009; 3(5):215-222.

  16. Perez-Padilla P, Rosa-Zamboni D, Ponce S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009;361:680-689.

  17. Cunha BA. Swine Influenza (H1N1) Pneumonia: clinical considerations. Infect Dis Clin N Am 2010;24:203-228.

  18. Chowell G, Bertozzi SM, Colchero M, et al. Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza. N Engl J Med 2009;361:674-679.

  19. Echevarría-Zuno S, Mejía JM, Mar AJ. Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009;374:2072-2079.

  20. Denise JJ, Margaret AH, Sonja AR. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009;374:451-458.

  21. Vanessa RL, Jeanne SS. Influenza and Pneumonia in pregnancy. Clin Perinatol 2005;32:727-738.

  22. Van Campen H, Easterday BC, Hinshaw VS. Destruction of lymphocytes by a virulent avia influenza A Virus. J Gen Virol 1989;70:467-472.

  23. Cui W, Zhao H, Lu X. Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China. BMC Infect Dis 2010;10:145.

  24. Brydon EW, Smith H, Sweet C. Influenza A virus induced apoptosis in bronchiolar epithelial (NCl-H292) cells limits proinflammatory citokine release. J Gen Virol 2003;84:2389-2400.

  25. Edward WA, Brydon A, Susan J, Morris B, Sweet C. Role of apoptosis and cytokines in influenza virus morbidity. FEMS Microbiology Reviews 2005;29:837-850.

  26. Drent M, Cobben NA, Henderson RF, Wouters Dieijen-Visser M. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J 1996;9:1736-1742.

  27. Glick JH. Serum lactate dehydrogenase isoenzyme and total lactate dehydrogenase values in health and disease, and clinical evaluation of these test by means of discriminant analysis. Am J Clin Pathol 1969;52:320-328.

  28. Henderson RF, Damon EG, Henderson TR. Early damage indicators in the lung. I. Lactate dehydrogenase activity in the airways. Toxicol Appl Pharmacol 1978;44:291-297.




2020     |     www.medigraphic.com